DOCSLIB.ORG

Original Article Bovine Immunodeficiency Virus and Bovine

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Original Article Bovine Immunodeficiency Virus and Bovine Original Article Bovine immunodeficiency virus and bovine leukemia virus and their mixed infection in Iranian Holstein cattle Gholamreza Nikbakht Brujeni1, Taghi Taghi Poorbazargani2, Susan Nadin-Davis3, Mohammad Tolooie4 and Neda Barjesteh1 1Department of Microbiology and Immunology, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran 2Department of Clinical Sciences, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran 3Ottawa Laboratory Fallowfield, Canadian Food Inspection Agency, Ottawa, ON, Canada 4Department of Clinical Sciences, Faculty of Veterinary Medicine, University of Tabriz, Tabriz, Iran Abstract Introduction: Bovine immunodeficiency virus (BIV) and bovine leukemia virus (BLV) have worldwide distributions, but their prevalences in Iran are unknown. We investigated the presence of infections in Iranian Holstein cattle and determined changes in hematological values for infected animals. Methodology: Nested PCR was used on blood samples from 143 animals Holstein cattle to detect proviral BIV and BLV gag sequences. Flow cytometric analysis was performed using monoclonal antibodies (mAbs) against CD4, CD8, and CD21 bovine T lymphocyte subsets. Results: Proviral BIV and BLV gag sequences were detected in 20.3% and 17% of the animals, respectively. BIV-BLV confection was also detected in 4.2% of the study population but this was not statistically significant. Flow cytometric analysis showed that both BIV-infected cows and non-infected ones had CD4/CD8 ratios of 2.45 and 1.43, respectively, and this difference was significant. BLV infected and non- infected animals had no significant differences in their CD4/CD8 ratio. In comparison to non-infected cattle, those with both BIV and BLV had a significant decrease in their CD4/CD8 ratios (1.5 % vs. 2.3; P = 0.01). Conclusion: This is the first report of BIV and BLV infections in Iran. We found no evidence that infection with one agent predisposed an animal to infection with the other. BIV infection may have a role in decreasing T CD8 counts, but this may depend on the genetics of the cattle and virus strains involved. Key words: bovine immunodeficiency virus; bovine leukemia virus/ nested PCR; flow cytometry; Iran J Infect Dev Ctries 2010; 4(9):576-579. (Received 29 November 2009 – Accepted 03 June 2010) Copyright © 2010 Brujeni et al. This is an open-access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Introduction Bovine immunodeficiency or immunodeficiency- The clinical significance of BIV infection may like virus (BIV) is a lentivirus of the family depend upon the strain of BIV, the breed of cattle, Retroviridae. It occurs widely with infections being and environmental stressors [2,6]. lifelong and generally subclinical [1,2]. In some Bovine leukaemia virus (BLV) is a lymphotropic instances, however, infections may be of economic retrovirus structurally related to human T-cell importance with seropositive cows having decreased leukaemia virus type 1 (HTLV-1) [14]. Following milk production [3-5]. Also, there is evidence that infection, the BLV can remain clinically dormant, BIV can cause immunosuppression with increased cause a persistent lymphocytosis (PL) with increased incidences of secondary bacterial infections and B lymphocytes, or cause B-cell lymphomas in lymph encephalitis found in herds with high seroprevalences nodes and other tissues. Only a few (< 5%) BLV- [4-9]. Following experimental infections, cattle may infected animals develop tumors [14]. have transient increases in lymphocytes, lymphoid As there is no data on BIV and BLV in Iran, we hyperplasia, atypical lymphosarcoma, and secondary conducted a survey of dairy cattle to determine the bacterial infections [6,10,11]. It has also been prevalence of single and concurrent infections. We suspected that the stress of parturition in BIV also determined the hematological effects of infected cows is associated with the progression of infections. bovine leukemia virus (BLV) infections [8,12,13]. Brujeni et al. - BIV and BLV in Iranian Holstein cattle J Infect Dev Ctries 2010; 4(9):576-579. Methodology PCR was also used to detect BLV proviral DNA as Whole blood and blood in EDTA were collected described previously by Wang et al. [18]. DNA from 143 apparently healthy Holstein cows in extracted from BLV-infected FLK cells (kindly Maysam slaughterhouse (Tehran, Iran). Complete provided by Razi Institute, Iran) was used as a blood counts were established by routine procedures positive control and the DNA sample prepared from a in the Tehran University laboratory. BLV-seronegative cow was used as negative control Single-colour staining for flow cytometric for PCR amplification. analysis was performed using the following PCR products generated from three BIV positive commercially available mAbs against bovine samples were cloned using a QIAGEN PCR cloning lymphocyte subsets (Serotec, Kidlington, England): kit (QIAGEN, Hilden, Germany) and sequenced CD4- fluorescein isothiocyanate (FITC), CD8-FITC commercially (Macrogen Inc., Seoul, Korea). and CD21- FITC. Mouse IgG1-FITC and IgG2a- Sequences were aligned and phylogenetic analyses were used as negative controls. performed with the Clustal programme available in Peripheral blood cells were lysed the software package of Bioedit version 7.0.5.3 (DakoCytomation Uti-Lyse Erythrocyte Lysing (http://jwbrown.mbio.ncsu.edu/Bioedit/bioedit.html). Reagent, Dako, Glostrup, Denmark) and lymphocytes Sequences obtained were deposited in GenBank were labeled using the mAbs according to the (EF661978, EF661979 and EF661980). manufacturer’s instructions. Flow cytometric analysis Data obtained from hematological and flow was performed by counting 10,000 cells from each cytometric experiments were analyzed by the SPSS sample on a FACS flow cytometer (Becton– 15.0 program using chi-square and Student’s t test. Dickinson and Co. Immunocytometry Systems, Franklin Lakes NJ, USA) and analyzed with Results CELLQuest software. Nested PCR identified 29 BIV-positive samples For the preparation of DNA, aliquots of whole giving an overall positivity rate of 20.3% (29/143). blood (500 μl) were added to 1 ml red blood cell lysis Similarly, 16.8% (24/143) were positive with the buffer (10 mM Tris-HCl pH 7.6; 5 mM MgCl2, 100 BLV-gag nested PCR. Six animals were positive for mM NaCl, 0.75 %Triton X-100) mixed and incubated both viruses (6/143; 4.2 %). at room temperature. After 2 minutes the tube was There was 98-100% identity when sequences of centrifuged at 12000 g for 20 seconds and the Iranian BIV amplicons (EF661978, EF661979 supernatant was discarded. The pellet was and EF661980) were compared with those of isolate resuspended in 600 μl of cell lysis buffer (10 mM R-29, confirming that BIV was detected in the Tris-HCl, pH 8; 0.1 M NaCl, 25 mM EDTA, pH 8; Iranian cattle we studied using our BIV specific 0.5% sodium dodecyl sulphate) and homogenized. primers. The sequences had no similarity with the Then 300 μl denaturing solution containing 4M bovine genome and other known related organisms guanidinium isothiocyanate, 25 mM sodium citrate (JDVCG). pH 7; 0.1 m 2ME and 0.5 % Sarkosyl was added and The only significant differences found, when incubated at room temperature. After 10 minutes, 300 comparing hematological and flow cytometery μl potassium acetate (3M potassium and 5M acetate) results, were the proportions of CD8 cells in BIV were added and vortexed for 30 seconds. After infected and non infected animals (27% and 21%; P ≤ centrifugation for 3 minutes at 12000g, 900 μl 0.05); the number of BIV and BLV infected animals supernatant were recovered and DNA precipitated (26% and 17%; P ≤ 0.5); and the proportions of CD4 with 600 μl isopropanol. The pellet was washed with cells in BLV infected and non infected animals (36% 70% ethanol and resuspended in 50 μl of TE (pH, and 30%; P ≤ 0.05). When CD4/CD8 ratios were 7.6). All samples were stored at -20°C until used. calculated, significant differences were also observed The DNA extracted from each blood sample was between BIV infected and non infected animals (1.4 used as a template to detect BIV proviral DNA by and 2.4; P ≤ 0.05) and BIV-BLV coinfected animals nested PCR as described previously by Nadin-Davis (1.5 and 2.3; P ≤ 0.5). et al. [17]. Plasmid DNA containing the complete BIV gag coding region (pGEM7-gag kindly provided Discussion by S. Nadin-Davis) served as a positive control. DNA Although BIV infected cattle have been from the animals that was consistently assayed as identified in some countries neighboring Iran [4,19], BIV negative was used as negative control. Nested to the best of our knowledge this is the first report of 577 Brujeni et al. - BIV and BLV in Iranian Holstein cattle J Infect Dev Ctries 2010; 4(9):576-579. BIV infection in Iranian Holstein cattle. Although we buffalo and cattle populations in Pakistan. J Vet Med Sci 62: studied only a small number of animals, the 329-331. 5. Snider TG, III, Hoyt PG, Coats KS, Graves KF, Cooper CR, prevalence we found of 20.3% is similar to that Storts RW, Luther DG, Jenny BF (2003) Natural bovine reported from other Asian countries (12% in Turkey lentiviral type 1 infection in Holstein dairy cattle. I. Clinical, [19] to 35% in Korea [20]), and neighboring serological, and pathological observations. Comp Immunol countries such as Pakistan (16 %) [4,13]. The Microbiol Infect Dis 26: 89-101. 6. Belloc C, Polack B, Schwartz-Cornil I, Brownlie J, Levy D prevalence of BLV infection (17%) in the current (1996) Bovine immunodeficiency virus: facts and questions. study was also similar to that of other Asian and non Vet Res 27: 395-402. Asian countries (9 to 33 %) [21-24]. 7. Isaacson JA, Flaming KP, Roth JA (1998) Effects of long- There was a significant increase in the CD4/CD8 term infection with bovine immunodeficiency virus and/or ratio in BIV-infected cows due to a significant bovine leukemia virus on antibody and lymphocyte proliferative responses in cattle.
Load more

Recommended publications
  • Combining Analysis of DNA in a Crude Virion Extraction with the Analysis of RNA from Infected Leaves to Discover New Virus Genomes
    Journal of Visualized Experiments www.jove.com Video Article Combining Analysis of DNA in a Crude Virion Extraction with the Analysis of RNA from Infected Leaves to Discover New Virus Genomes Jeanmarie Verchot1, Aastha Thapa2, Dulanjani Wijayasekara3, Peter R. Hoyt4 1 Texas A&M Agrilife Center at Dallas 2 Noble Research Center, Oklahoma State University 3 Department of Biology, College of Engineering and Natural Sciences, The University of Tulsa 4 Bioinformatics and Genomics Core Facility, Department of Biochemistry and Molecular Biology, Oklahoma State University Correspondence to: Jeanmarie Verchot at [email protected] URL: https://www.jove.com/video/57855 DOI: doi:10.3791/57855 Keywords: Immunology and Infection, Issue 137, Virus purification, plant virus, next-generation sequencing, badnavirus, virus metagenomics, virus Date Published: 7/27/2018 Citation: Verchot, J., Thapa, A., Wijayasekara, D., Hoyt, P.R. Combining Analysis of DNA in a Crude Virion Extraction with the Analysis of RNA from Infected Leaves to Discover New Virus Genomes. J. Vis. Exp. (137), e57855, doi:10.3791/57855 (2018). Abstract This metagenome approach is used to identify plant viruses with circular DNA genomes and their transcripts. Often plant DNA viruses that occur in low titers in their host or cannot be mechanically inoculated to another host are difficult to propagate to achieve a greater titer of infectious material. Infected leaves are ground in a mild buffer with optimal pH and ionic composition recommended for purifying most bacilliform Para retroviruses. Urea is used to break up inclusion bodies that trap virions and to dissolve cellular components. Differential centrifugation provides further separation of virions from plant contaminants.
    [Show full text]
  • Bovine Leukemia Virus (BLV) Infection (Cumulative Percentages*)
    June 2014 James Evermann, Professor Bovine Leukosis – Where have we been? Bovine leukosis (leukemia) virus infection has been monitored in the United States cattle population since the late 1970’s when a serologic test was first introduced (14). Prior to that time there was sporadic clinical evidence dating back to the late 1800’s that cattle were susceptible to infectious cancer (13). The agent was first identified in 1969, and that discovery allowed for development of various diagnostic tests. Over the past 40 years testing has allowed us to monitor for BLV infection from its subclinical phase to the clinical phase, and construct reliable control strategies for BLV infection in herds, regions, and in some cases, complete eradication (12). Initially, there were two reasons to control BLV. They were first centered on reduction of carcass condemnation at meat processing plants, and the second was to improve trade-marketing of cattle within regions and between countries. Since overt clinical forms of bovine leukosis were being noticed less due to cows shorter duration of time on the farm (primarily dairy cattle), trade restrictions between countries were the predominant reasons to test for and certify populations of cattle as “BLV free” (16). Recently, there has been renewed interest in controlling BLV within the United States not only for improvement of trade-marketing of cattle, but also because of newer data, which affirms that BLV infection has a negative effect on dairy cattle production (1, 6). These data, in addition to reports of BLV genomic segments being found in human tissues have prompted this update (5, 10).
    [Show full text]
  • Retroviral Infections in Sheep and Goats: Small Ruminant Lentiviruses and Host Interaction
    Viruses 2013, 5, 2043-2061; doi:10.3390/v5082043 OPEN ACCESS viruses ISSN 1999-4915 www.mdpi.com/journal/viruses Review Retroviral Infections in Sheep and Goats: Small Ruminant Lentiviruses and Host Interaction Amaia Larruskain and Begoña M. Jugo * Genomics and Health Group, Department of Genetics, Physical Anthropology and Animal Physiology, Faculty of Science and Technology, University of the Basque Country UPV/EHU, Bilbao 48080, Spain; E-Mail: [email protected] * Author to whom correspondence should be addressed; E-Mail: [email protected]; Tel.: +34-94-601-5518. Received: 3 June 2013; in revised form: 26 July 2013 / Accepted: 5 August 2013 / Published: 19 August 2013 Abstract: Small ruminant lentiviruses (SRLV) are members of the Retrovirus family comprising the closely related Visna/Maedi Virus (VMV) and the Caprine Arthritis- Encephalitis Virus (CAEV), which infect sheep and goats. Both infect cells of the monocyte/macrophage lineage and cause lifelong infections. Infection by VMV and CAEV can lead to Visna/Maedi (VM) and Caprine Arthritis-Encephalitis (CAE) respectively, slow progressive inflammatory diseases primarily affecting the lungs, nervous system, joints and mammary glands. VM and CAE are distributed worldwide and develop over a period of months or years, always leading to the death of the host, with the consequent economic and welfare implications. Currently, the control of VM and CAE relies on the control of transmission and culling of infected animals. However, there is evidence that host genetics play an important role in determining Susceptibility/Resistance to SRLV infection and disease progression, but little work has been performed in small ruminants.
    [Show full text]
  • Pathobiology of Bovine Leukemia Virus I Schwartz, D Lévy
    Pathobiology of bovine leukemia virus I Schwartz, D Lévy To cite this version: I Schwartz, D Lévy. Pathobiology of bovine leukemia virus. Veterinary Research, BioMed Central, 1994, 25 (6), pp.521-536. hal-00902257 HAL Id: hal-00902257 https://hal.archives-ouvertes.fr/hal-00902257 Submitted on 1 Jan 1994 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Review article Pathobiology of bovine leukemia virus I Schwartz D Lévy URA-INRA d’Immuno-Pathologie Cellulaire et Moléculaire, École Nationale Vétérinaire dAlfort, 7, avenue du Général-de-Gaulle, 94704 Maisons-Alfort cedex, France (Received 16 March 1994; accepted 25 July 1994) Summary &horbar; Bovine leukemia virus (BLV) is a retrovirus similar to the human T-cell leukemia virus (HTLV). Most BLV infected animals (70%) develop a B-cell lymphoproliferative syndrome with altered productive traits and 1 to 5% die with B-cell lymphosarcomas. Although BLV infection is worid-wide, west- ern European countries have almost eradicated it by slaughtering the seropositive animals. BLV infec- tion remains endemic in many countries including the United States and prophylactic strategies involv- ing recombinant vaccine vectors, genetically modified BLV and transgenic animals resistant to the infection are under study.
    [Show full text]
  • Lymphadenopathy-Associated Virus and Molecular Cloning Of
    Proc. Natl. Acad. Sci. USA Vol. 83, pp. 9754-9758, December 1986 Medical Sciences Cross-reactivity to human T-lymphotropic virus type III/ lymphadenopathy-associated virus and molecular cloning of simian T-cell lymphotropic virus type III from African green monkeys (simian retrovirus/unintegrated viral DNA/acquired immunodeficiency syndrome/nucleic acid hybridization) VANESSA HIRSCH, NORBERT RIEDEL, HARDY KORNFELD, PHYLLIS J. KANKI, M. ESSEX, AND JAMES I. MULLINS* Department of Cancer Biology, Harvard School of Public Health, 665 Huntington Avenue, Boston, MA 02115 Communicated by Norman Davidson, September 10, 1986 ABSTRACT Simian T-lymphotropic retroviruses with STLV-III viruses also share a tropism and are cytopathic for structural, antigenic, and cytopathic features similar to the human T4 lymphocytes in culture (11-17), suggesting that etiologic agent of human acquired immunodeficiency syn- study of STLV-III may yield insight into mechanisms of drome, human T-lymphotropic virus type III/lymph- disease induction relevant to human acquired immunodefi- adenopathy-associated virus (HTLV-I/LAV), have been iso- ciency syndrome (AIDS). lated from a variety of primate species including African green STLV-III was first identified in captive, ill rhesus monkeys monkeys (STLV-IIIAGM). This report describes nucleic acid (Macaca mulatta) in the United States (STLV-IImac) (12, 13) cross-reactivity between STLV-UIAGM and HTLV-Il/LAV, and a very similar virus was found in a large proportion of molecular cloning of the STLV-IIIAGM genome, and evaluation
    [Show full text]
  • Silencers of HTLV-1 and HTLV-2
    Harrod Retrovirology (2019) 16:25 https://doi.org/10.1186/s12977-019-0487-9 Retrovirology REVIEW Open Access Silencers of HTLV-1 and HTLV-2: the pX-encoded latency-maintenance factors Robert Harrod* Abstract Of the members of the primate T cell lymphotropic virus (PTLV) family, only the human T-cell leukemia virus type-1 (HTLV-1) causes disease in humans—as the etiological agent of adult T-cell leukemia/lymphoma (ATLL), HTLV-1-as- sociated myelopathy/tropical spastic paraparesis (HAM/TSP), and other auto-infammatory disorders. Despite having signifcant genomic organizational and structural similarities, the closely related human T-cell lymphotropic virus type-2 (HTLV-2) is considered apathogenic and has been linked with benign lymphoproliferation and mild neuro- logical symptoms in certain infected patients. The silencing of proviral gene expression and maintenance of latency are central for the establishment of persistent infections in vivo. The conserved pX sequences of HTLV-1 and HTLV-2 encode several ancillary factors which have been shown to negatively regulate proviral gene expression, while simul- taneously activating host cellular proliferative and pro-survival pathways. In particular, the ORF-II proteins, HTLV-1 p30 II and HTLV-2 p28II, suppress Tax-dependent transactivation from the viral promoter—whereas p30 II also inhibits PU.1- mediated infammatory-signaling, diferentially augments the expression of p53-regulated metabolic/pro-survival genes, and induces lymphoproliferation which could promote mitotic proviral replication. The ubiquitinated form of the HTLV-1 p13II protein localizes to nuclear speckles and interferes with recruitment of the p300 coactivator by the viral transactivator Tax. Further, the antisense-encoded HTLV-1 HBZ and HTLV-2 APH-2 proteins and mRNAs negatively regulate Tax-dependent proviral gene expression and activate infammatory signaling associated with enhanced T-cell lymphoproliferation.
    [Show full text]
  • REVIEW Molecular and Cellular Aspects of HTLV-1 Associated
    Leukemia (2003) 17, 26–38 2003 Nature Publishing Group All rights reserved 0887-6924/03 $25.00 www.nature.com/leu REVIEW Molecular and cellular aspects of HTLV-1 associated leukemogenesis in vivo F Mortreux1,3, A-S Gabet1 and E Wattel1,2 1Unite´ d’Oncogene`se Virale, UMR5537 CNRS-Universite´ Claude Bernard, Centre Le´ ´on Be´rard, Lyon, France; and 2Service d’He´matologie, Pavillon E, Hoˆpital Edouard Herriot, Lyon, France Most cancers and leukemias are preceded by a prolonged per- leukemia/lymphoma (ATLL).2,3 Furthermore, this virus has iod of clinical latency during which cellular, chromosomal and been associated with the development of a chronic progress- molecular aberrations help move normal cell towards the malig- ive neuromyelopathy (tropical spastic paraparesis (TSP)/HTLV- nant phenotype. The problem is that premalignant cells are 4 usually indistinguishable from their normal counterparts, ther- 1-associated myelopathy (HAM)), and, to a lesser extent, to eby ruling out the possibility to investigate the events that a variety of inflammatory diseases.5–9 govern early leukemogenesis in vivo. Adult T cell Among the 15–25 million individuals infected worldwide, leukemia/lymphoma (ATLL) is a T cell malignancy that occurs approximately 3% to 5% will develop ATLL, depending on as after a 40–60-year period of clinical latency in about 3–5% of yet unknown cofactors. ATLL harbors different clinical fea- HTLV-1-infected individuals. ATLL cells are monoclonally expanded and harbor an integrated provirus. A persistent tures resulting in a division of the spectrumof the disease into 10,11 oligo/polyclonal expansion of HTLV-1-bearing cells has been four clinical subtypes referred to as acute, lymphoma, shown to precede ATLL, supporting the fact that in ATLL tumor chronic and smoldering subtypes.
    [Show full text]
  • Process Infectivity at Multiple Steps of the Entry Responses and Directly
    Antibodies to the Envelope Glycoprotein of Human T Cell Leukemia Virus Type 1 Robustly Activate Cell-Mediated Cytotoxic Responses and Directly Neutralize Viral This information is current as Infectivity at Multiple Steps of the Entry of September 26, 2021. Process Chien-Wen S. Kuo, Antonis Mirsaliotis and David W. Brighty Downloaded from J Immunol published online 6 June 2011 http://www.jimmunol.org/content/early/2011/06/06/jimmun ol.1100070 http://www.jimmunol.org/ Supplementary http://www.jimmunol.org/content/suppl/2011/06/06/jimmunol.110007 Material 0.DC1 Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision by guest on September 26, 2021 • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2011 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. Published June 6, 2011, doi:10.4049/jimmunol.1100070 The Journal of Immunology Antibodies to the Envelope Glycoprotein of Human T Cell Leukemia Virus Type 1 Robustly Activate Cell-Mediated Cytotoxic Responses and Directly Neutralize Viral Infectivity at Multiple Steps of the Entry Process Chien-Wen S.
    [Show full text]
  • Download Download
    Research, Society and Development, v. 10, n. 9, e13010917900, 2021 (CC BY 4.0) | ISSN 2525-3409 | DOI: http://dx.doi.org/10.33448/rsd-v10i9.17900 Cytomorphological similarities between feline viral leukemia, bovine enzootic leukosis and adult T-cell leukemia/lymphoma: A review Semelhanças citomorfológicas entre a leucemia viral felina, leucose enzoótica bovina e leucemia/linfoma de células T do adulto: Revisão de literatura Similitudes citomorfológicas entre la leucemia viral felina, la leucosis bovina enzoótica y la leucemia/linfoma de células T adultas: Revisión de literatura Received: 07/05/2021 | Reviewed: 07/11/2021 | Accept: 07/12/2021 | Published: 07/22/2021 Júlia Meireles da Silva Silveira ORCID: https://orcid.org/0000-0001-5553-1499 Universidade de Vassouras, Brazil E-mail: [email protected] Sheila de Oliveira Medeiros ORCID: https://orcid.org/0000-0001-5492-1532 Organização Pan-Americana da Saúde, Brazil E-mail: [email protected] Renata Fernandes Ferreira de Moraes ORCID: https://orcid.org/0000-0001-7129-1587 Universidade de Vassouras, Brazil E-mail: [email protected] Erica Cristina Rocha Roier ORCID: https://orcid.org/0000-0002-1978-9254 Universidade de Vassouras, Brazil E-mail: [email protected] Bruna de Azevedo Baêta ORCID: https://orcid.org/0000-0002-0172-556X Universidade de Vassouras, Brazil E-mail: [email protected] Letícia Patrão de Macedo Gomes ORCID: https://orcid.org/0000-0003-1373-9069 Universidade de Vassouras, Brazil E-mail: [email protected] Gustavo Mendes Gomes ORCID: https://orcid.org/0000-0002-4967-8029 Universidade de Vassouras, Brazil E-mail: [email protected] Ana Paula Abreu ORCID: https://orcid.org/0000-0001-6385-3906 Universidade de Vassouras, Brazil E-mail: [email protected] Abstract Leukemias are malignant neoplasms of hematological origin and originating from bone marrow cells.
    [Show full text]
  • Infected Cattle
    Turk. J. Vet. Anim. Sci. 2008; 32(3): 207-214 © TÜB‹TAK Research Article Clinical and Haematological Findings in Bovine Immunodeficiency Virus (BIV) Infected Cattle Zeki YILMAZ1,*, Kadir YEfi‹LBA⁄2 1Department of Internal Medicine, Faculty of Veterinary Medicine Uluda¤ University, Bursa - TURKEY 2Department of Virology, Faculty of Veterinary Medicine, Uluda¤ University, Bursa - TURKEY Received: 02.03.2007 Abstract: The clinical and haematological findings in dairy cattle with naturally infected bovine immunodeficiency virus (BIV) infection were evaluated. Thirty-seven (12.3%) out of 300 cattle that had previously been found positive for BIV infection were monitored. Thirty-seven BIV-free cattle selected from BIV-positive herds were used as a control group. Routine clinical and haematological parameters were recorded 6 times, at 1-month intervals. Mastitis (n = 18), metritis (n = 9), respiratory system diseases (n = 8), retained placenta (n = 7), and regional lymphadenopathy (n = 7) were predominantly diagnosed during the monitoring period in BIV-infected cattle, and mastitis (n = 1) and metabolic disturbance (n = 1) in the control animals. Heart and respiratory rates were significantly higher (P < 0.01) in BIV-infected cattle than in the control group. White blood cell (WBC) count and lymphocyte rate were lower (P < 0.01) in BIV-infected cattle, but the neutrophil rate was higher (P < 0.05) than those of the control group. There were no significant differences in erythrocyte or platelet indices within or between the groups during the study. These findings suggest that the presence of BIV infection should be considered a health risk to cattle populations, and may have a role in changing WBC and differential cell counts in the host.
    [Show full text]
  • Latest Clinical Discoveries on Retroviruses and Chronic Disease
    Latest Clinical Discoveries on Retroviruses and Chronic Disease Dietrich Klinghardt MD, PhD AONM Annual Conference Holiday Inn Regents Park, London 17th November 2019 Agenda 1. What are retroviruses (RVs)? Endogenous and exogenous RVs Conditions they are associated with 2. Towards detecting the activation of RVs 3. The treatment of retroviral activation/infection Proven biological remedies Pharmaceuticals What are retroviruses? Retroviruses are viruses composed not of DNA (a double-stranded helix: deoxyribonucleic acid), but of RNA (single-stranded: ribonucleic acid). They use an enzyme called reverse transcriptase that gives them the unique property of transcribing their RNA into DNA after entering a cell. Once inside the cell, it uses that enzyme to force the cell to create viral DNA. This viral DNA becomes integrated into the host-cell DNA.1 Retroviruses are in effect retrograde, because the flow of genetic information is reversed compared with the normal pathway of molecular biosynthesis—DNA → RNA → protein. “Subsequent retrotransposition events amplified these sequences, resulting in approximately 8% of the human genome being composed of HERV sequences today.”2 – passed down to us from our ancestors as battle-scars from our constant encounter with an often hostile microbial and virus-rich environment (Stoyle.,2006, Mayer et al.,2011; Li et al.,2001). A retrovirus integrated into our genome may be passed from mother to child during pregnancy (Sakuma et al.,2012). These viruses are referred to as Human Endogenous Retroviruses or HERVs. Source: 1. www.medicinenet.com; 2. Li W, Lee MH, Henderson L, Tyagi R, Bachani M, Steiner J, Campanac E, Hoffman DA, von Geldern G, Johnson K, Maric D, Morris HD, Lentz M, Pak K, Mammen A, Ostrow L, Rothstein J, Nath A.
    [Show full text]
  • Bovine Leukemia Virus DNA in Human Breast Tissue Gertrude Case Buehring, Hua Min Shen, Hanne M
    RESEARCH Bovine Leukemia Virus DNA in Human Breast Tissue Gertrude Case Buehring, Hua Min Shen, Hanne M. Jensen, K. Yeon Choi,1 Dejun Sun, and Gerard Nuovo Bovine leukemia virus (BLV), a deltaretrovirus, causes unlike other oncogenic retroviruses, deltaretroviruses B-cell leukemia/lymphoma in cattle and is prevalent in herds have an additional region, tax (trans-activating region of globally. A previous finding of antibodies against BLV in hu- the X gene), which has regulatory functions and is onco- mans led us to examine the possibility of human infection genic to host cells. tax causes malignant transformation with BLV. We focused on breast tissue because, in cattle, not through integration and insertional mutagenesis, as BLV DNA and protein have been found to be more abun- many retroviruses do, but by inhibition of DNA repair dant in mammary epithelium than in lymphocytes. In human breast tissue specimens, we identified BLV DNA by using (base excision pathway) and trans-activating disruption nested liquid-phase PCR and DNA sequencing. Variations of cellular growth control mechanisms (2). from the bovine reference sequence were infrequent and BLV-infected cattle herds are found worldwide. In the limited to base substitutions. In situ PCR and immunohisto- United States, ≈38% of beef herds, 84% of all dairy herds, chemical testing localized BLV to the secretory epithelium and 100% of large-scale dairy operation herds are infected of the breast. Our finding of BLV in human tissues indicates (3,4). On average, clinical leukosis develops in <5% of these a risk for the acquisition and proliferation of this virus in cattle, which are excluded from the market as a result (1), but humans.
    [Show full text]